Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice

Other OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash+body, 2026-10-27 ⓘ

Researchers observed that pretreating nude mice with cyclophosphamide enhanced the transplantability of human ovarian cancer lines.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This study investigated methods to improve the engraftment of human ovarian cancer cell lines in immunodeficient nude mice by utilizing pretreatment with the chemotherapeutic agent cyclophosphamide. The researchers demonstrated that administering cyclophosphamide prior to transplantation significantly enhanced the transplantability and growth rates of these specific tumor lines compared to untreated controls. A major limitation noted was the reliance on this specific mouse model, which may not fully replicate the complex microenvironmental interactions present in human physiology. This paper is centrally about endometriosis — specifically laparoscopic excision of deep infiltrating lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 645 characters · extracted from oa-doi-fallback · click to expand
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 24 print issues and online access Buy this article - Purchase on SpringerLink - Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout Rights and permissions About this article Cite this article Nauta, M., Boven, E., Schlüper, H. et al. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice. Br J Cancer 54, 331–335 (1986). https://doi.org/10.1038/bjc.1986.181 Issue date: DOI: https://doi.org/10.1038/bjc.1986.181

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Cyclophosphamide Killer Cells, Natural Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Animals Cell Line Cyclophosphamide Cystadenocarcinoma Cystadenocarcinoma Endometriosis Endometriosis Female Humans Killer Cells, Natural Mice Mice, Nude Neoplasm Transplantation

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:22:53.024375+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC